Drugs Import Process in Nepal

29 May

Table of Contents

Drugs import process in Nepal is governed by a comprehensive regulatory framework designed to ensure that all pharmaceutical products entering the country meet strict standards of safety, efficacy, and quality. The process is overseen by the Department of Drug Administration (DDA) under the Ministry of Health and Population, and it involves multiple stages from company registration to customs clearance. This guide has been prepared to help importers navigate every step with clarity and confidence.

What Is the Drugs Import Process in Nepal?

The drugs import process in Nepal refers to the complete sequence of regulatory, administrative, and customs procedures that must be completed before pharmaceutical products can be legally imported, distributed, and sold within the country. Unlike general imports, drug imports require specialized licensing, product registration, and quality verification to protect public health.

The process is anchored in the Drug Act 2035 (1978 A.D.), Drug Registration Regulation 2038, and Drug Standard Regulation 2043, with enforcement carried out by the DDA and supported by the National Medicines Laboratory (NML).

Legal Framework for Drugs Import in Nepal

The drugs import process in Nepal is regulated by the following primary legislation:

Legislation	Year (B.S./A.D.)	Scope
Drug Act	2035 / 1978	Primary law governing manufacture, sale, distribution, import, and export of drugs
Drug Registration Regulation	2038 / 1981	Detailed procedures for drug registration, licensing, and import authorization
Drug Standard Regulation	2043 / 1986	Quality standards, testing protocols, and pharmacopoeial references
National Drug Policy	2052 / 1995	Policy framework for drug production, import, quality assurance, and rational use
National GMP Code	2072 / 2015	Good Manufacturing Practice standards for pharmaceutical operations
Medicine Registration Guidance	2073 / 2016	Detailed guidance on drug registration procedures and documentation

Key Regulatory Authorities in Drugs Import Process

Authority	Role in Import Process
Department of Drug Administration (DDA)	Primary regulator for drug registration, licensing, and import authorization
National Medicines Laboratory (NML)	Conducts analytical testing and quality verification of imported drugs
Department of Customs	Handles customs clearance, duty assessment, and border control
Department of Industry (DOI)	Issues industrial registration for pharmaceutical businesses
Inland Revenue Department (IRD)	Manages PAN/VAT registration and tax compliance
Nepal Rastra Bank (NRB)	Regulates foreign currency transactions for imports

Types of Drug Licenses in Nepal

Before initiating the drugs import process in Nepal, the appropriate license type must be identified:

License Type	Purpose	Typical Timeline
Import Registration Certificate	Required for each drug product to be imported	6-12 months
Import/Export Recommendation Letter	Issued for each shipment of registered drugs	5-10 working days
Wholesale Certificate	Required for distribution of drugs to retailers	2-4 months
Retail Pharmacy Certificate	Required for selling drugs directly to consumers	1-3 months
Manufacturing License	Required for domestic drug production	6-12 months

Step-by-Step Drugs Import Process in Nepal

Step 1: Establish Import Business Entity

A Nepali drug wholesale firm registered with DDA must be established. The entity must be authorized by the foreign manufacturing company through a letter of attorney.

Step 2: Obtain Foreign Manufacturer Approval

For new manufacturing companies, approval must be sought from DDA with:

Application on company letterhead
Letter of authority to the importer
Site Master File (as per PICS guidelines)
Up-to-date manufacturing license
List of products intended for registration
Letter of warranty
Latest GMP internal audit report
Complete dossier of one product
WHO-GMP compliance approval (for non-SRA, non-UN prequalified products)
Risk evaluation and mitigation strategy

Step 3: Register Drug Products with DDA

Each drug product must be registered before importation. The application must include:

Document	Requirement
Schedule 4C application form	DDA prescribed format
Manufacturing license	Up-to-date, issued by home country drug authority
Certificate of Pharmaceutical Product (CPP)	WHO-recommended format, attested by drug authority or notary
Product formulation	API, excipients, color, flavor, packaging details
Product specification	Complete analytical standards
Analytical test report	From NML or DDA-approved laboratory
Label and packaging samples	Duplex box, catch cover, cartoon samples
Product samples	2 unit packs minimum
Stability data	Accelerated (0, 3, 6 months) and real-time testing
Bioavailability/Bioequivalence study	Required for generic products
Batch manufacturing records	Commercial batch details

Step 4: Obtain Import Registration Certificate

Upon satisfactory review, DDA issues an import registration certificate (Schedule 4E). The certificate fee is NPR 200 initially and NPR 100 for renewal.

Step 5: Apply for Import Recommendation Letter

For each shipment, an import recommendation letter must be obtained from DDA using Schedule 6 application form. The fee is NPR 200 initially and NPR 100 for renewal.

Step 6: Customs Clearance and Import

Upon arrival at the border, the following documents must be submitted to customs:

Document	Purpose
Commercial invoice	Value and quantity of goods
Packing list	Detailed shipment contents
Bill of lading / Airway bill	Proof of transport
Import recommendation letter from DDA	Regulatory authorization
Import registration certificate	Product approval verification
Customs declaration form (CMR)	Legal clearance document
EXIM code	Mandatory trade registration
Certificate of origin	Manufacturing country verification

Customs duties and taxes are assessed based on HS code classification. The standard calculation involves:

Tax Component	Rate	Base
Basic Customs Duty	0% - 80%	CIF value
Value Added Tax (VAT)	13%	CIF + customs duty
Excise Duty	Varies	Applicable to specific products
Agriculture Development Fee	5%	Agricultural goods
Customs Service Fee	NPR 500	Per import declaration

Step 7: Post-Import Compliance

After clearance, imported drugs must be stored according to Good Storage and Distribution Practices (GSDP). Temperature-sensitive products require controlled environments. Batch traceability records must be maintained for inspection by authorities.

Fees and Costs in Drugs Import Process

Fee Type	Amount (NPR)	Notes
Industry establishment recommendation	200	One-time
Product license	200 initial / 50 renewal	Per product
Sale and distribution registration	100 initial / 50 renewal	Per entity
Import registration certificate	200 initial / 100 renewal	Per product
Import/export recommendation letter	200 initial / 100 renewal	Per shipment
Foreign manufacturer inspection	USD 1,500	For SAARC countries
Industry registration fee	50,000	One-time
NML testing fees	5,000 - 50,000	Per product
Professional/consultant fees	Variable	Document preparation, legal assistance
Customs duties and taxes	Variable	Based on CIF value and HS code

Timeline for Drugs Import Process in Nepal

Stage	Duration	Authority
Foreign manufacturer approval	2-4 months	DDA
Drug product registration	6-12 months (imported drugs)	DDA
Import recommendation letter	5-10 working days	DDA
Customs clearance	3-7 days	Department of Customs
NML testing (if required)	2-4 weeks	NML
Total estimated time	8-18 months	—

Special Import Provisions

Life-Saving Medicines

For life-saving medicines with prescription from a registered medical practitioner, DDA may issue import recommendation letters in required quantities upon application with supporting evidence.

Donation Imports

Governmental or non-governmental agencies importing drugs through donation must obtain DDA import recommendation letters. Donation guidelines are available on the DDA official website.

International Competitive Bidding

Drugs imported through international competitive bidding require DDA import recommendation letters specifying products and quantities.

Personal Use

Medicines for personal use may be imported with prescription from a registered practitioner, subject to quantity justification and DDA approval.

Prohibited and Restricted Imports

Category	Restriction
Unregistered drugs	Cannot be imported without DDA registration
Drugs without authorized wholesaler	Companies without Nepali authorized importer are barred
Narcotic and psychotropic substances	Special DDA recommendation required; coordinated with INCB
Drugs from barred manufacturers	As notified by DDA through official communiqué
Counterfeit or substandard drugs	Complete prohibition

Penalties for Non-Compliance

Offense	Penalty
Importing without license	Imprisonment up to 3 years and/or fine
Selling adulterated drugs	Imprisonment up to 3 years and/or fine
Selling expired drugs	Imprisonment up to 3 years and/or fine
False advertising	License suspension and fines
Unauthorized clinical trials	Imprisonment and fines under Third Amendment
General fine ceiling	Up to NPR 100,000 or amount in controversy, whichever is higher

Recent Developments in Drug Import Regulation

Development	Year	Significance
Emergency Use Authorization	2079 B.S.	DDA can register drugs for emergency use during epidemics
Good Pharmacy Practices (GPP)	2080 B.S.	First national guidelines for 27,000+ pharmacies
Good Storage and Distribution Practices (GSDP)	2080 B.S.	National standards for 5,000+ drug wholesalers
Revised Codes on Sale and Distribution	2080 B.S.	Updated standards replacing 2071 version
Fourth Amendment to Drug Act	2082 B.S.	Further modernization of regulatory provisions
Electronic regulatory system	Ongoing	Integrated system for marketing authorization, surveillance, and licensing

How CorporateNp Supports Drugs Import Process in Nepal

CorporateNp provides comprehensive assistance for pharmaceutical importers navigating the drugs import process in Nepal. Services include:

DDA registration and licensing support
Document preparation and dossier compilation
Foreign manufacturer approval facilitation
Product registration application filing
Import recommendation letter assistance
Customs clearance coordination
Tax registration and compliance
GSDP compliance advisory
Ongoing regulatory compliance guidance

Contact CorporateNp for expert consultation and streamlined processing of your drug import operations in Nepal.

Frequently Asked Questions (FAQs)

Q1: What is the drugs import process in Nepal for new importers?

New importers must first establish a DDA-registered wholesale firm, obtain foreign manufacturer approval, register each drug product, secure import registration certificates, and obtain recommendation letters for each shipment before customs clearance.

Q2: How long does drug product registration take in Nepal?

Imported drug registration typically takes 6 to 12 months, depending on documentation completeness, NML testing requirements, and DDA evaluation timelines.

Q3: What documents are required for drug import registration in Nepal?

Required documents include Schedule 4C application form, manufacturing license, Certificate of Pharmaceutical Product (CPP), product formulation, specifications, analytical test reports, stability data, label samples, and product samples.

Q4: Can foreign companies directly import drugs into Nepal?

No, foreign companies must appoint an authorized Nepali wholesale firm registered with DDA. Direct import without local representation is not permitted.

Q5: What are the fees for drug import registration in Nepal?

The import registration certificate fee is NPR 200 initially and NPR 100 for renewal. Additional fees include product license (NPR 200/50), recommendation letters (NPR 200/100), and NML testing (NPR 5,000-50,000).

Q6: Are life-saving medicines exempt from import registration?

Life-saving medicines may be imported with DDA recommendation letters upon application with medical practitioner prescriptions and supporting evidence, but standard registration requirements still apply for commercial distribution.

Q7: What customs duties apply to imported drugs in Nepal?

Customs duties vary by product category (0%-80% basic customs duty), plus 13% VAT on CIF plus duty value. Specific pharmaceutical products may qualify for reduced rates or exemptions.

Q8: How often must drug import licenses be renewed?

Import registration certificates and recommendation letters are valid for two years and must be renewed annually within 35 days of expiry, with additional fees for late renewal.

Q9: What happens if imported drugs fail NML testing?

Drugs failing NML quality testing may be rejected, destroyed, or returned to the manufacturer. The importer may face penalties and suspension of import privileges.

Q10: Can donated drugs be imported without registration?

Donated drugs require DDA import recommendation letters and must comply with donation guidelines. Standard registration may be waived for specific humanitarian shipments with proper authorization.

References

Disclaimer: This blog is provided for general informational purposes only and does not constitute legal advice, solicitation, or personal communication. CorporateNp assumes no liability for actions taken based on the information contained herein. For personalized legal assistance, please contact a qualified attorney or regulatory consultant in Nepal.

About CorporateNp: CorporateNp is a leading business consultancy and legal service provider in Nepal, specializing in pharmaceutical licensing, drug registration, import compliance, company registration, and regulatory advisory. Contact us today to streamline your drugs import process in Nepal.